Interdisciplinary multimodality management of stage III nonsmall cell lung cancer
RM Huber, D De Ruysscher… - European …, 2019 - Eur Respiratory Soc
Stage III nonsmall cell lung cancer (NSCLC) comprises about one-third of NSCLC patients
and is very heterogeneous with varying and mostly poor prognosis. It is also called …
and is very heterogeneous with varying and mostly poor prognosis. It is also called …
[PDF][PDF] Interdisciplinary multimodality management of stage III nonsmall cell lung cancer
RM Huber, D De Ruysscher, H Hoffmann, S Reu… - 2019 - scholar.archive.org
Stage III nonsmall cell lung cancer (NSCLC) comprises about one-third of NSCLC patients
and is very heterogeneous with varying and mostly poor prognosis. It is also called …
and is very heterogeneous with varying and mostly poor prognosis. It is also called …
Interdisciplinary multimodality management of stage III nonsmall cell lung cancer.
RM Huber, D De Ruysscher… - European …, 2019 - search.ebscohost.com
Stage III nonsmall cell lung cancer (NSCLC) comprises about one-third of NSCLC patients
and is very heterogeneous with varying and mostly poor prognosis. It is also called" …
and is very heterogeneous with varying and mostly poor prognosis. It is also called" …
[PDF][PDF] Interdisciplinary multimodality management of stage III nonsmall cell lung cancer
RM Huber, D De Ruysscher, H Hoffmann, S Reu… - 2019 - scienceopen.com
Stage III nonsmall cell lung cancer (NSCLC) comprises about one-third of NSCLC patients
and is very heterogeneous with varying and mostly poor prognosis. It is also called …
and is very heterogeneous with varying and mostly poor prognosis. It is also called …
[PDF][PDF] Interdisciplinary multimodality management of stage III nonsmall cell lung cancer
RM Huber, D De Ruysscher… - European …, 2019 - mediatum.ub.tum.de
Stage III nonsmall cell lung cancer (NSCLC) comprises about one-third of NSCLC patients
and is very heterogeneous with varying and mostly poor prognosis. It is also called …
and is very heterogeneous with varying and mostly poor prognosis. It is also called …
[HTML][HTML] Interdisciplinary multimodality management of stage III nonsmall cell lung cancer
RM Huber, D De Ruysscher, H Hoffmann… - European Respiratory …, 2019 - ncbi.nlm.nih.gov
Stage III nonsmall cell lung cancer (NSCLC) comprises about one-third of NSCLC patients
and is very heterogeneous with varying and mostly poor prognosis. It is also called …
and is very heterogeneous with varying and mostly poor prognosis. It is also called …
[HTML][HTML] Interdisciplinary multimodality management of stage III nonsmall cell lung cancer
RM Huber, D De Ruysscher… - European …, 2019 - Eur Respiratory Soc
Stage III nonsmall cell lung cancer (NSCLC) comprises about one-third of NSCLC patients
and is very heterogeneous with varying and mostly poor prognosis. It is also called …
and is very heterogeneous with varying and mostly poor prognosis. It is also called …
Interdisciplinary multimodality management of stage III nonsmall cell lung cancer
RM Huber, D De Ruysscher… - European …, 2019 - epub.ub.uni-muenchen.de
Stage III nonsmall cell lung cancer (NSCLC) comprises about one-third of NSCLC patients
and is very heterogeneous with varying and mostly poor prognosis. It is also called" …
and is very heterogeneous with varying and mostly poor prognosis. It is also called" …
Interdisciplinary multimodality management of stage III nonsmall cell lung cancer.
RM Huber, D De Ruysscher, H Hoffmann… - … Review: an Official …, 2019 - europepmc.org
Stage III nonsmall cell lung cancer (NSCLC) comprises about one-third of NSCLC patients
and is very heterogeneous with varying and mostly poor prognosis. It is also called …
and is very heterogeneous with varying and mostly poor prognosis. It is also called …
Interdisciplinary multimodality management of stage III nonsmall cell lung cancer
RM Huber, D De Ruysscher… - … review: an official …, 2019 - pubmed.ncbi.nlm.nih.gov
Stage III nonsmall cell lung cancer (NSCLC) comprises about one-third of NSCLC patients
and is very heterogeneous with varying and mostly poor prognosis. It is also called" …
and is very heterogeneous with varying and mostly poor prognosis. It is also called" …